Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
MAUDE Adverse Event Report: LIFESTYLES; LATEX CONDOM
FDA Home
Medical Devices
Databases
-
510(k)
|
DeNovo
|
Registration & Listing
|
Adverse Events
|
Recalls
|
PMA
|
HDE
|
Classification
|
Standards
CFR Title 21
|
Radiation-Emitting Products
|
X-Ray Assembler
|
Medsun Reports
|
CLIA
|
TPLC
LIFESTYLES; LATEX CONDOM
Back to Search Results
Medical Device Problem Code
Cross Reactivity (1137)
Health Effect - Clinical Code
Reaction (2414)
Date of Event
09/06/2016
Type of Reportable Event
Serious Injury
Event or Problem Description
On (b)(6) 2016 consumer upon using the product got a severe reaction and had to go to the emergency room because genital area had swelling.No other information provided at the time of the event.
Search Alerts/Recalls
New Search
|
Submit an Adverse Event Report
Brand Name
LIFESTYLES
Common Device Name
LATEX CONDOM
MDR Report Key
5943598
Report Number
1019632-2016-00008
Device Sequence Number
10127739
Product Code
HIS
Combination Product (Y/N)
N
Initial Reporter State
NJ
Initial Reporter Country
US
Number of Events Summarized
1
Summary Report (Y/N)
N
Reporter Type
Importer
Initial Reporter Occupation
Other
Type of Report
Initial
Report Date
(Section B)
09/12/2016
Report Date
(Section F)
09/12/2016
1
Device was Involved in the Event
1
Patient was Involved in the Event
Is this an Adverse Event Report?
Yes
Operator of Device
No Information
Was Device Available for Evaluation?
No
Was the Report Sent to FDA?
Yes
Distributor Facility Aware Date
09/06/2016
Event Location
Home
Type of Report(Section G)
Thirty-Day
Initial Date Received by Manufacturer
Not provided
Initial Report FDA Received Date
09/12/2016
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number
1
Outcome Attributed to Adverse Event
Hospitalization;
Patient Age
18 YR
Date Report Sent to FDA
09/12/2016
-
-